At Delee, we aim to radically change the way cancer is detected, monitored and treated. Through the development of the CytoCatch™, which is a highly sensitive automated benchtop device, we have made possible to rapidly isolate and efficiently analyze circulating tumor cells from blood samples.
The CytoCatch™ is comprised of a fully automated sample processing unit and an imaging system which, along with the embedded artificial intelligence it possesses, inhibits human mistakes due to manual sample handling, and suppresses subjective interpretation errors.
This innovative technology enables not only the early detection of cancer, but also the continuous monitoring of the disease’s evolution and the effectiveness of therapies that are being administered; increasing the patient’s chances of defeating cancer.
Welcome to the new generation of cancer management.